# ABCELLERA BIOLOGICS INC (ABCL)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/ABCL/

- Reporting holders: 4
- Reported value: $559.4K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Green Alpha Advisors, LLC](https://holderbook.com/funds/1439207-green-alpha-advisors-llc/) | $334.5K | 22,930 | 0.2% | 21 |
| [DKM Wealth Management, Inc.](https://holderbook.com/funds/2055833-dkm-wealth-management-inc/) | $145.9K | 10,000 | 0.1% | 8 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $47.9K | 3,283 | 0.0% | 12 |
| [Pacifica Partners Inc.](https://holderbook.com/funds/1799900-pacifica-partners-inc/) | $31.0K | 2,230 | 0.0% | 24 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $559.4K |
| Q2 2026 | 152 | $1.0B |
| Q1 2026 | 139 | $457.2M |
| Q4 2025 | 147 | $381.5M |
| Q3 2025 | 146 | $543.9M |
| Q2 2025 | 130 | $377.7M |
| Q1 2025 | 131 | $305.4M |
| Q4 2024 | 145 | $336.2M |
| Q3 2024 | 139 | $276.7M |
| Q2 2024 | 148 | $339.9M |
| Q1 2024 | 155 | $556.5M |
| Q4 2023 | 145 | $695.8M |